{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:01:06Z","timestamp":1790035266984,"version":"4.0.1"},"reference-count":47,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department of Radiology, Feinberg School of Medicine, Northwestern University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tomography"],"abstract":"<jats:p>Background\/Objectives: Radiomic features exhibit a correlation with tumor size on pretreatment images. However, on post-treatment images, this association is influenced by treatment efficacy and varies between responders and non-responders. This study introduces a novel model, called baseline-referenced Delta radiomics, which integrates the association between radiomic features and tumor size into Delta radiomics to predict chemotherapy response in liver metastases from breast cancer (BC) and colorectal cancer (CRC). Materials and Methods: A retrospective study analyzed contrast-enhanced computed tomography (CT) scans of 83 BC patients and 84 CRC patients. Among these, 57 BC patients with 106 liver lesions and 37 CRC patients with 109 lesions underwent post-treatment imaging after systemic chemotherapy. Radiomic features were extracted from up to three lesions per patient following manual segmentation. Tumor response was assessed by measuring the longest diameter and classified according to RECIST 1.1 criteria as progressive disease (PD), partial response (PR), or stable disease (SD). Classification models were developed to predict chemotherapy response using pretreatment data only, Delta radiomics, and baseline-referenced Delta radiomics. Model performance was evaluated using confusion matrix metrics. Results: Baseline-referenced Delta radiomics performed comparably or better than established radiomics models in predicting tumor response in chemotherapy-treated patients with liver metastases. The sensitivity, specificity, and balanced accuracy in predicting response ranged from 0.66 to 0.97, 0.81 to 0.97, and 80% to 90%, respectively. Conclusions: By integrating the relationship between radiomic features and tumor size into Delta radiomics, baseline-referenced Delta radiomics offers a promising approach for predicting chemotherapy response in liver metastases from breast and colorectal cancer.<\/jats:p>","DOI":"10.3390\/tomography11030020","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T06:10:21Z","timestamp":1740031821000},"page":"20","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Delta Radiomics and Tumor Size: A New Predictive Radiomics Model for Chemotherapy Response in Liver Metastases from Breast and Colorectal Cancer"],"prefix":"10.3390","volume":"11","author":[{"given":"Nicol\u00f2","family":"Gennaro","sequence":"first","affiliation":[{"name":"Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moataz","family":"Soliman","sequence":"additional","affiliation":[{"name":"Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir A.","family":"Borhani","sequence":"additional","affiliation":[{"name":"Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Kelahan","sequence":"additional","affiliation":[{"name":"Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2156-9664","authenticated-orcid":false,"given":"Hatice","family":"Savas","sequence":"additional","affiliation":[{"name":"Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Avery","sequence":"additional","affiliation":[{"name":"Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Subedi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugce A.","family":"Trabzonlu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chase","family":"Krumpelman","sequence":"additional","affiliation":[{"name":"Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Yaghmai","sequence":"additional","affiliation":[{"name":"Department of Radiological Sciences, University of California Irvine, Irvine, CA 92868, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"Chae","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"},{"name":"Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Lorch","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"},{"name":"Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2979-9894","authenticated-orcid":false,"given":"Devalingam","family":"Mahalingam","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"},{"name":"Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Mulcahy","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"},{"name":"Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al","family":"Benson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"},{"name":"Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulas","family":"Bagci","sequence":"additional","affiliation":[{"name":"Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"},{"name":"Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2287-5727","authenticated-orcid":false,"given":"Yuri S.","family":"Velichko","sequence":"additional","affiliation":[{"name":"Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA"},{"name":"Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrc3261","article-title":"Intra-tumour heterogeneity: A looking glass for cancer?","volume":"12","author":"Marusyk","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature12625","article-title":"The causes and consequences of genetic heterogeneity in cancer evolution","volume":"501","author":"Burrell","year":"2013","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12943-017-0600-4","article-title":"Intra-tumor heterogeneity from a cancer stem cell perspective","volume":"16","author":"Prasetyanti","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/s41556-022-00969-x","article-title":"Untangling the web of intratumour heterogeneity","volume":"24","author":"Li","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Stanta, G., and Bonin, S. (2018). Overview on Clinical Relevance of Intra-Tumor Heterogeneity. Front. Med., 5.","DOI":"10.3389\/fmed.2018.00085"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1158\/1078-0432.CCR-14-0990","article-title":"Imaging intratumor heterogeneity: Role in therapy response, resistance, and clinical outcome","volume":"21","author":"Rose","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.crad.2016.09.013","article-title":"Unravelling tumour heterogeneity using next-generation imaging: Radiomics, radiogenomics, and habitat imaging","volume":"72","author":"Sala","year":"2017","journal-title":"Clin. Radiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","article-title":"Radiomics: Extracting more information from medical images using advanced feature analysis","volume":"48","author":"Lambin","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: Images are more than pictures, they are data","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jamaoncol.2016.2631","article-title":"The Potential of Radiomic-Based Phenotyping in Precision Medicine: A Review","volume":"2","author":"Aerts","year":"2016","journal-title":"JAMA Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1148\/radiol.2021202553","article-title":"The Biological Meaning of Radiomic Features","volume":"298","author":"Tomaszewski","year":"2021","journal-title":"Radiology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11547-024-01853-4","article-title":"Delta radiomics: An updated systematic review","volume":"129","author":"Nardone","year":"2024","journal-title":"La Radiol. Medica"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Cousin, F., Louis, T., Dheur, S., Aboubakar, F., Ghaye, B., Occhipinti, M., Vos, W., Bottari, F., Paulus, A., and Sibille, A. (2023). Radiomics and Delta-radiomics signatures to predict response and survival in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors. Cancers, 15.","DOI":"10.3390\/cancers15071968"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Giannini, V., Pusceddu, L., Defeudis, A., Nicoletti, G., Cappello, G., Mazzetti, S., Sartore-Bianchi, A., Siena, S., Vanzulli, A., and Rizzetto, F. (2022). Delta-radiomics predicts response to first-line oxaliplatin-based chemotherapy in colorectal cancer patients with liver metastases. Cancers, 14.","DOI":"10.3390\/cancers14010241"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.3748\/wjg.v29.i19.2888","article-title":"Radiomics in colorectal cancer patients","volume":"29","author":"Inchingolo","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1007\/s00261-021-03085-w","article-title":"Radiomics of hepatocellular carcinoma: Promising roles in patient selection, prediction, and assessment of treatment response","volume":"46","author":"Borhani","year":"2021","journal-title":"Abdom. Radiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yacr.2023.06.001","article-title":"A Comprehensive Review of Deep Learning Approaches for Magnetic Resonance Imaging Liver Tumor Analysis","volume":"5","author":"Velichko","year":"2023","journal-title":"Adv. Clin. Radiol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ye, S., Han, Y., Pan, X., Niu, K., Liao, Y., and Meng, X. (2022). Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.843991"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"6654","DOI":"10.1038\/s41467-021-26990-6","article-title":"Deep learning for the prediction of early on-treatment response in metastatic colorectal cancer from serial medical imaging","volume":"12","author":"Lu","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2967\/jnumed.114.144055","article-title":"18F-FDG PET uptake characterization through texture analysis: Investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort","volume":"56","author":"Hatt","year":"2015","journal-title":"J. Nucl. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/mp.12123","article-title":"Intrinsic dependencies of CT radiomic features on voxel size and number of gray levels","volume":"44","author":"Zhang","year":"2017","journal-title":"Med. Phys."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Roy, S., Whitehead, T.D., Quirk, J.D., Salter, A., Ademuyiwa, F.O., Li, S., An, H., and Shoghi, K.I. (2020). Optimal co-clinical radiomics: Sensitivity of radiomic features to tumour volume, image noise and resolution in co-clinical T1-weighted and T2-weighted magnetic resonance imaging. EBioMedicine, 59.","DOI":"10.1016\/j.ebiom.2020.102963"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.acra.2020.03.004","article-title":"Association Between the Size and 3D CT-Based Radiomic Features of Breast Cancer Hepatic Metastasis","volume":"28","author":"Velichko","year":"2021","journal-title":"Acad. Radiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e2200023","DOI":"10.1200\/CCI.22.00023","article-title":"A Framework for Harmonization of Radiomics Data for Multicenter Studies and Clinical Trials","volume":"6","author":"Soliman","year":"2022","journal-title":"JCO Clin. Cancer Inform."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future","volume":"168","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Liang, Y., Li, Q., He, D., Chen, Y., and Li, J. (2021). Tumor size improves the accuracy of the prognostic prediction of T4a stage colon cancer. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-95828-4"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1200\/JCO.21.00445","article-title":"Oligometastases for Clinicians: Size Matters","volume":"39","author":"Girard","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e2018110118","DOI":"10.1073\/pnas.2018110118","article-title":"Evolutionary dynamics at the tumor edge reveal metabolic imaging biomarkers","volume":"118","author":"Bosque","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1158\/0008-5472.CAN-18-0125","article-title":"LIFEx: A freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity","volume":"78","author":"Nioche","year":"2018","journal-title":"Cancer Res."},{"key":"ref_33","unstructured":"Zwanenburg, A., Leger, S., Valli\u00e8res, M., and L\u00f6ck, S. (2016). Image biomarker standardisation initiative. arXiv."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s11547-021-01436-7","article-title":"Delta radiomics: A systematic review","volume":"126","author":"Nardone","year":"2021","journal-title":"Radiol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v028.i05","article-title":"Building Predictive Models in R Using the caret Package","volume":"28","author":"Kuhn","year":"2008","journal-title":"J. Stat. Softw."},{"key":"ref_36","unstructured":"R Core Team (2021). R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing. Available online: https:\/\/www.R-project.org."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2018-316407","article-title":"Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab","volume":"69","author":"Dohan","year":"2020","journal-title":"Gut"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s11547-019-01046-4","article-title":"Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: A pilot study including comparison with standard chemotherapy","volume":"124","author":"Ravanelli","year":"2019","journal-title":"Radiol. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1177\/0284185118817940","article-title":"Texture in the monitoring of regorafenib therapy in patients with colorectal liver metastases","volume":"60","author":"Andersen","year":"2019","journal-title":"Acta Radiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/mp.14563","article-title":"Deep learning-based radiomics predicts response to chemotherapy in colorectal liver metastases","volume":"48","author":"Wei","year":"2021","journal-title":"Med. Phys."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Giannini, V., Defeudis, A., Rosati, S., Cappello, G., Mazzetti, S., Panic, J., Regge, D., and Balestra, G. (2020, January 20\u201324). An innovative radiomics approach to predict response to chemotherapy of liver metastases based on CT images. Proceedings of the 2020 42nd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC), Montreal, QC, Canada.","DOI":"10.1109\/EMBC44109.2020.9176627"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/jnci\/djaa017","article-title":"Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway","volume":"112","author":"Dercle","year":"2020","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.3748\/wjg.v27.i38.6465","article-title":"Magnetic resonance imaging-radiomics evaluation of response to chemotherapy for synchronous liver metastasis of colorectal cancer","volume":"27","author":"Ma","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Fan, M., Chen, H., You, C., Liu, L., Gu, Y., Peng, W., Gao, X., and Li, L. (2021). Radiomics of Tumor Heterogeneity in Longitudinal Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer. Front. Mol. Biosci., 8.","DOI":"10.3389\/fmolb.2021.622219"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Guo, L., Du, S., Gao, S., Zhao, R., Huang, G., Jin, F., Teng, Y., and Zhang, L. (2022). Delta-Radiomics Based on Dynamic Contrast-Enhanced MRI Predicts Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Cancers, 14.","DOI":"10.3390\/cancers14143515"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Yang, M., Liu, H., Dai, Q., Yao, L., Zhang, S., Wang, Z., Li, J., and Duan, Q. (2022). Treatment Response Prediction Using Ultrasound-Based Pre-, Post-Early, and Delta Radiomics in Neoadjuvant Chemotherapy in Breast Cancer. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.748008"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"He, M., Hu, Y., Wang, D., Sun, M., Li, H., Yan, P., Meng, Y., Zhang, R., Li, L., and Yu, D. (2022). Value of CT-Based Radiomics in Predicating the Efficacy of Anti-HER2 Therapy for Patients With Liver Metastases From Breast Cancer. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.852809"}],"container-title":["Tomography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2379-139X\/11\/3\/20\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:38:47Z","timestamp":1760027927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2379-139X\/11\/3\/20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["tomography11030020"],"URL":"https:\/\/doi.org\/10.3390\/tomography11030020","relation":{},"ISSN":["2379-139X"],"issn-type":[{"value":"2379-139X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]}}}